Discover how we are championing this cause, together.

Learn about the progress being made across the country and in your own backyard.

March 15, 2023

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer (Q-CROC) are teaming up to optimize the support available to women affected by ovarian cancer in Quebec.

February 15, 2023

Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island

Women living in Prince Edward Island (PEI) now have access to precision treatments for ovarian cancer, thanks to Ovarian Cancer Canada’s advocacy efforts.

February 8, 2023

Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world

Every 5 hours, we lose someone we love to ovarian cancer in Canada. Ovarian cancer is the most fatal women’s cancer and sadly, one in two diagnosed do not live to see another five years.

December 16, 2022

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

Two funded clinical trials, though different in their approach and focus, share a dedication to exploring innovative treatment pathways and a made-in-Canada pedigree.

December 16, 2022

Clinical Trial: New biomarkers, improved treatment pathways

Two funded clinical trials, though different in their approach and focus, share a dedication to exploring innovative treatment pathways and a made-in-Canada pedigree.

November 29, 2022

Research knows no bounds

Ovarian Cancer Canada takes a multi-pronged approach to ensure that all types of the disease, even the rarest ones, are prioritized to ensure that everyone benefits from the best available science as quickly as possible.

June 17, 2022

Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada

Qingchuan Zhao’s research awarded the 2022 Anita Unruh Prize from Ovarian Cancer Canada

December 7, 2021

Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million

Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million in ovarian cancer research: Funding for 10 new projects just announced

August 17, 2021

Harnessing the power of vaccines to treat ovarian cancer

Most of us have recently heard a great deal about how vaccines help protect against the serious effects of COVID-19. But did you know that vaccines can also be used to treat disease?

Connect with us

Have a question or want to speak with a team member?

Get in touch